ALLBIRDS INC-CL A (BIRD)

US01675A1097 - Common Stock

0.6126  0 (-0.54%)

After market: 0.619 +0.01 (+1.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BIRD. BIRD was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. No worries on liquidiy or solvency for BIRD as it has an excellent financial health rating, but there are worries on the profitability. BIRD is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year BIRD has reported negative net income.
BIRD had a negative operating cash flow in the past year.
In the past 5 years BIRD always reported negative net income.
BIRD had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

BIRD's Return On Assets of -48.76% is on the low side compared to the rest of the industry. BIRD is outperformed by 88.00% of its industry peers.
Looking at the Return On Equity, with a value of -82.27%, BIRD is doing worse than 84.00% of the companies in the same industry.
Industry RankSector Rank
ROA -48.76%
ROE -82.27%
ROIC N/A
ROA(3y)-26.66%
ROA(5y)-19.99%
ROE(3y)-41.9%
ROE(5y)-31.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of BIRD (41.03%) is worse than 64.00% of its industry peers.
BIRD's Gross Margin has declined in the last couple of years.
BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5Y-4.06%

7

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BIRD has more shares outstanding
Compared to 5 years ago, BIRD has more shares outstanding
BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

BIRD has an Altman-Z score of -1.12. This is a bad value and indicates that BIRD is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.12, BIRD is not doing good in the industry: 86.00% of the companies in the same industry are doing better.
BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC9.59%

2.3 Liquidity

A Current Ratio of 4.37 indicates that BIRD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.37, BIRD belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
A Quick Ratio of 3.18 indicates that BIRD has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.18, BIRD belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 3.18

5

3. Growth

3.1 Past

The earnings per share for BIRD have decreased strongly by -38.89% in the last year.
The Revenue for BIRD has decreased by -14.68% in the past year. This is quite bad
Measured over the past years, BIRD shows a very strong growth in Revenue. The Revenue has been growing by 68.35% on average per year.
EPS 1Y (TTM)-38.89%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-50%
Revenue 1Y (TTM)-14.68%
Revenue growth 3Y5.03%
Revenue growth 5Y68.35%
Revenue growth Q2Q-14.48%

3.2 Future

BIRD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
Based on estimates for the next years, BIRD will show a quite strong growth in Revenue. The Revenue will grow by 15.43% on average per year.
EPS Next Y-0.19%
EPS Next 2Y8.19%
EPS Next 3Y15.08%
EPS Next 5Y13.04%
Revenue Next Year-21.03%
Revenue Next 2Y-10.52%
Revenue Next 3Y13.94%
Revenue Next 5Y15.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

BIRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIRD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BIRD's earnings are expected to grow with 15.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.19%
EPS Next 3Y15.08%

0

5. Dividend

5.1 Amount

No dividends for BIRD!.
Industry RankSector Rank
Dividend Yield N/A

ALLBIRDS INC-CL A

NASDAQ:BIRD (4/26/2024, 7:00:00 PM)

After market: 0.619 +0.01 (+1.04%)

0.6126

0 (-0.54%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap95.07M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.76%
ROE -82.27%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.37
Quick Ratio 3.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-38.89%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-0.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.68%
Revenue growth 3Y5.03%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y